|
209 Pharmacists
facing sharp increase in Society fees Pharmacists are facing a 25 per cent increase in next year’s annual retention fee for membership of the Royal Pharmaceutical Society
...more
209 Third
wave of 11 LPS pilots approved in England Eleven third-wave
local pharmaceutical services (LPS) pilots have been approved by the
Department of Health for England ...more
209 Generics
price fixing allegations extended to more companies Legal
proceedings against two manufacturers for alleged price fixing over the
sale of generic ranitidine to the NHS have been extended to three further
companies: Norton Healthcare Ltd, Norton Pharmaceuticals Ltd and Kent
Pharmaceuticals Ltd ...more
209 New
NHS walk-in centres At least one of 17 new NHS walk-in centres
announced last week will have an on-site pharmacy ...more
210 Three
new vaccines for childhood immunisation Three new vaccines
are to be included in the childhood immunisation programme used across
Britain from September ...more
210 Cycling
of antibiotics in hospitals is unlikely to prevent resistance The
practice of alternating between different classes of antibiotic agents
in hospitals is unlikely to reduce the spread of resistance, according
to the authors of a new study ...more
210 DTB finds moxifloxacin lacking but Bayer refutes criticism Oral moxifloxacin (Avelox), a quinolone antibiotic licensed for use in several respiratory infections, offers “no compelling advantages over established treatments”, according to August’s Drug and Therapeutics Bulletin
...more
211 Steady
progress made on new contract in Scotland Negotiations over the new community pharmacy contract in Scotland are making steady progress, and roll-out of another of the contract’s four core service pilots is expected to begin next month
...more
211 Boots
wins a full service hospital contract Boots the Chemists is to operate a hospital pharmacy at a private finance initiative hospital in Darlington. It is the company’s first foray into the managed sector
...more
211 Free
cholesterol test at Boots Free cholesterol tests for people at risk of heart disease are being offered by Boots the Chemists as part of a new “Kick cholesterol” health promotion campaign
...more
211 Checklist
for OTC training A checklist to help manufacturers of over-the-counter
medicines produce training materials to support pharmacy retail staff
has been launched ...more
211 Lloyds
diabetes screening Half a million Lloydspharmacy customers have been screened for type 2 diabetes since the launch of the company’s free blood glucose testing service in June 2003
...more
211 New
CE at Alliance UniChem Alliance UniChem has appointed Ian
Meakins, president for major markets and global supply for drinks business
Diageo Plc, as its new chief executive ...more
211 NHS in Scotland
report Audit Scotland’s latest report examines the performance of the NHS in Scotland
...more
|
212 Pharmacists
do not need to check prescriptions written by every nurse for formulary
compliance Community pharmacists do not need to police
formulary compliance by extended formulary and supplementary nurse
prescribers, according to guidance issued by London, Eastern and
South East Specialist Pharmacy Services. However, they do need to
continue to check prescribing by district nurses and health visitors
...more
212 New roles
for practitioners with a special interest in genetics New
funding for primary care health professionals to train as experts in
genetics was announced last week. Although the scheme is primarily aimed
at GPs, the Department of Health says that it will welcome approaches
from other practitioners in primary care in England who are interested
in developing roles in genetics ...more
212 Patients
still lack information about medicines, surveys shows Patients
still do not receive enough information about their care, although overall
they rate the NHS highly, according to the latest surveys carried out
by the Healthcare Commission ...more
213 Call for
comparative atypical antipsychotic trials Further evidence
to help prescribers decide which atypical antipsychotic agent is best
for an individual patient is urgently needed, according to a review in
this month’s Drug and Therapeutics Bulletin, because each
agent has a different side effect profile ...more
213 First-line
use of paracetamol for osteoarthritis in doubt The recommendation
that paracetamol should be used as first-line treatment for osteoarthritis
is called into question by the authors of two studies ...more
213 New clozapine
brand will reduce NHS costs Special discount arrangements
between the manufacturers of a new brand of clozapine tablets launched
this week could provide considerable cost savings to the NHS ...more
R & D news
216 Genetically
engineered vaccines could reduce common allergies More effective
vaccines against common allergies could be developed in the future using
genetically engineered allergen derivatives, new research suggests ...more
216 Early immunotherapy
could halt Alzheimer’s progression Progression of Alzheimer’s
disease may be halted by early use of immunotherapy designed to target
beta-amyloid plaques, researchers have found ...more
216 Dendrimer
hope for scar prevention Dendrimers (tree-like molecules formed
from branched polymers) that are designed to have immunomodulatory and
antiangiogenic properties can be used to prevent scar tissue formation,
laboratory studies suggest ...more
216 Patients
with multiple sclerosis should be offered cannabinoid when licence approved Dronabinol,
a cannabinoid, should be available as a treatment option to patients
with multiple sclerosis whose pain does not respond adequately to other
drugs, say researchers from Denmark ...more
|
The
Pharmaceutical Journal